The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2025

Filed:

Feb. 22, 2021
Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

Neeta Balkrishan Amin, Cambridge, MA (US);

Arthur James Bergman, Salem, CT (US);

Roberto Arnaldo Calle, Marlborough, MA (US);

William Paul Esler, Clinton, CT (US);

Albert Myung Kim, Newton, MA (US);

Jeffrey Allen Pfefferkorn, Acton, MA (US);

Patrick Robert Verhoest, Newton, MA (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 31/438 (2006.01); A61P 1/16 (2006.01); A61P 3/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/438 (2013.01); A61P 1/16 (2018.01); A61P 3/00 (2018.01); C07B 2200/13 (2013.01);
Abstract

A method for treating fatty liver disease and related diseases or disorders with a therapeutically effective amount of a composition comprising from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceutically acceptable salt thereof, and from about 5 mg to about 40 mg of 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…